Selenite transport by SLC26A6 contributes to redox homeostasis and ferroptosis resistance
In the authors' words
Selenium is an essential micronutrient widely found in dietary supplements and fortified foods and is required for selenoprotein synthesis and function. Although the molecular mechanisms of selenium-dependent selenoprotein translation are well understood, its uptake mechanisms remain only partially characterized. Using a CRISPR-based loss-of-function screen, we identify the solute carrier SLC26A6 as a direct selenite transporter. Using biochemical, cellular, and in vivo studies, we show that SLC26A6 directly transports selenite and promotes selenoprotein translation, redox homeostasis, and ferroptosis resistance. Additionally, we report the first human-specific SLC26A6 inhibitor and determine the structure of the SLC26A6-inhibitor complex by cryo-electron microscopy. These findings identify a previously uncharacterized route of inorganic selenium uptake and establish SLC26A6 as a pharmacologically tractable determinant of selenoprotein synthesis, redox homeostasis, and ferroptosis resistance.
In plain words AI summary
The researchers used a CRISPR screen to find that the protein SLC26A6 transports selenite, a form of selenium. They showed that SLC26A6 helps make selenoproteins, maintains redox balance, and protects cells from ferroptosis. The team also created the first human-specific inhibitor of SLC26A6 and determined its structure using cryo-electron microscopy. These findings reveal a new way cells take in inorganic selenium and show SLC26A6 can be targeted with drugs.
Written by Kimi K2.5 using only the abstract above. Jev checked that every sentence is supported by the abstract sentences it cites, and removed any that were not. Point at a sentence to highlight its source.
Appeared: Wednesday, November 18. bioRxiv. Preprint, not yet peer-reviewed.